by Jon Fleetwood, Jon Fleetwood: FDA approved the injection for seniors before any clinical benefit was shown, and before confirming vaccinated can’t shed vaccine components onto unvaccinated, raising informed consent concerns. Yesterday, Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has “approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all […]